Axsome's (AXSM-0.50%) revenue is soaring thanks to strong momentum for two drugs -- Auvelity and Sunosi. The company launched Auvelity in October 2022 as a treatment for major depressive disorder. It ...
By Tom Covilli, Vice President of Safety and Risk Management. Developing a best-in-class safety program in any business, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results